BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
BNB$591.85+3.54%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
BNB$591.85+3.54%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
Thermo Fisher Scientific beat Q4 expectations with EPS of $6.57 on revenue of $12.21 billion and shared its outlook for 2026.
Thermo Fisher Scientific reported 5% revenue growth in Q3 2025 with adjusted EPS of $5.79, beating expectations and reinforcing its positive long-term outlook.
Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.
Thermo Fisher Scientific Inc. (NYSE: TMO) reported a revenue of $10.60 billion in the third quarter of 2024.
Thermo Fisher Scientific reported $10.54 billion in revenue for Q2 2024.
Thermo Fisher Scientific Inc. has showcased its financial strength in the first quarter of 2024, with a slight revenue decline but commendable growth in GAAP diluted…
Thermo Fisher Scientific Inc. (NYSE: TMO) has reported a strong fourth quarter for 2023, surpassing financial expectations with a slight increase in EPS and higher-than-expected revenue.